Fake Marijuana News: What the Cannabis Media Isn’t Telling Investors About the D.C. Circuit Rescheduling Challenge
See the complaint. When Commentary Becomes Advocacy? WASHINGTON, D.C. / ACCESS Newswire / June 13, 2026 / In the rush...
Pharmaceutical
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and durable effectsNew analyses showed patients...
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat...
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Data from HAELO Phase 3 clinical trial presented today in a late-breaking oral session at European Academy of Allergy &...
HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support
Horsewood 7-Herb Formula: Tongkat Ali 100:1, Horny Goat Weed, Saw Palmetto, Wild Yam, Nettle, Sarsaparilla, Boron Ingredients and GuaranteeLargo, FL,...
Marijuana Rescheduling Delayed or Denied? Marijuana Faces its Biggest Threat Yet: the Constitution
"Before the DEA's June 29 Rescheduling Hearing Proceeds, a Foundational Question Demands an Answer: Is This Process Constitutional" asked Duane...
BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Not for distribution to U.S. newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire /...
Rythmia Life Advancement Center Launches Interactive ‘Safety Hub’ to Provide Unprecedented Transparency in the Plant Medicine Industry
SANTA CRUZ, COSTA RICA / ACCESS Newswire / June 12, 2026 / As the global demand for plant-based therapies and...
Pharmacy Podcast Network and YARAL Pharma Announce “Care in Motion” Community Tour Across Southwestern Pennsylvania
Tour will spotlight two Western Pennsylvania independent community pharmacies, Curtis Pharmacy and Asti's South Hills Pharmacy, highlighting the evolving role...
eviCore by Evernorth Rated #1 as Prior Authorization Becomes a Top Health Plan Technology Acquisition Priority
Q2 2026 Black Book payer IT client scores recognize top performance in PA workflow control, UM execution, medical-policy governance, clinical...
Medical Care Technologies (OTC PINK:MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform
Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation MESA, AZ / ACCESS Newswire...
Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company’s Crofelemer Development Program for Rare Intestinal Failure Diseases
Click here to register for eventTo access the replay of the June 10, 2026 presentation by Lisa Conte, Jaguar's founder,...
CVS Health To Deliver Faster, More Personalized Call Center Care for Millions of Members With Salesforce’s Agentforce Health
Collaboration will improve call center experience for members and 1.5 million providers with AI agentsOriginally published on CVS Health Company...
Managed Care Clients Rate Trend Health Partners #1 in Payment Integrity, FWA, SIU, COB, Subrogation and Recovery in Black Book Research 2026 Payer IT Survey
Eight-month payer IT study recognizes top client-scored achievement in one of managed care's highest-return operating categories as health plans tighten...
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control...
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
Data from the RALLY-MF trial of DISC-0974 in patients with myelofibrosis (MF) and anemia demonstrate meaningful, durable overall anemia responses...
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS • Addressing a Multi-Hundred-Billion-Dollar...
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
PALO ALTO, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative...
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2...
Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting
Oral presentation at JDA features new data from the KT-621 Phase 1 study in healthy Japanese adults, with safety and...